tradingkey.logo
tradingkey.logo
검색

Twist Bioscience Corp

TWST
관심 목록에 추가
99.240USD
-3.010-2.94%
종가 07/02, 13:00ET시세는 15분 지연됩니다
6.08B시가총액
손실P/E TTM

Twist Bioscience Corp

99.240
-3.010-2.94%

자세한 내용은 Twist Bioscience Corp 회사

Twist Bioscience Corporation is a synthetic biology and genomics company that has developed a deoxyribonucleic acid (DNA) synthesis platform to industrialize the engineering of biology. The Company's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. It has applied its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next generation sequencing (NGS) sample preparation, and antibody libraries for drug discovery and development, all designed to enable its customers to conduct research. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The Company also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The Company's synthetic DNA tools are used in fields, such as medicine, agriculture, industrial chemicals and defense. It has minority ownership in Atlas Data Storage, Inc.

Twist Bioscience Corp 정보

종목 코드 TWST
회사 이름Twist Bioscience Corp
상장일Oct 31, 2018
CEOLeproust (Emily M)
직원 수979
유형Ordinary Share
회계 연도 종료Oct 31
주소681 Gateway Blvd.
도시SOUTH SAN FRANCISCO
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호94080
전화18007190671
웹사이트https://www.twistbioscience.com/
종목 코드 TWST
상장일Oct 31, 2018
CEOLeproust (Emily M)

Twist Bioscience Corp의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
368.47K
-6.20%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
99.15K
+5.14%
Mr. Patrick John Finn, Ph.D.
Mr. Patrick John Finn, Ph.D.
President, Chief Operating Officer
President, Chief Operating Officer
65.04K
-10.77%
Mr. Nelson C. Chan
Mr. Nelson C. Chan
Independent Director
Independent Director
28.78K
+17.70%
Ms. Paula Green
Ms. Paula Green
Senior Vice President - Human Resources
Senior Vice President - Human Resources
23.50K
-5.00%
Mr. Dennis Cho
Mr. Dennis Cho
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
21.34K
-70.08%
Dr. Melissa A. Starovasnik, Ph.D.
Dr. Melissa A. Starovasnik, Ph.D.
Independent Director
Independent Director
17.75K
-16.90%
Mr. Jan Johannessen
Mr. Jan Johannessen
Independent Director
Independent Director
13.28K
--
Mr. Adam Laponis
Mr. Adam Laponis
Chief Financial Officer
Chief Financial Officer
7.12K
-84.57%
Ms. Trynka Shineman Blake
Ms. Trynka Shineman Blake
Director
Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
368.47K
-6.20%
Mr. Keith L. Crandell
Mr. Keith L. Crandell
Independent Director
Independent Director
99.15K
+5.14%
Mr. Patrick John Finn, Ph.D.
Mr. Patrick John Finn, Ph.D.
President, Chief Operating Officer
President, Chief Operating Officer
65.04K
-10.77%
Mr. Nelson C. Chan
Mr. Nelson C. Chan
Independent Director
Independent Director
28.78K
+17.70%
Ms. Paula Green
Ms. Paula Green
Senior Vice President - Human Resources
Senior Vice President - Human Resources
23.50K
-5.00%
Mr. Dennis Cho
Mr. Dennis Cho
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
21.34K
-70.08%

자주 묻는 질문

Twist Bioscience Corp의 상위 5대 주주는 누구인가요?

Twist Bioscience Corp의 상위 5대 주주는 다음과 같습니다: Dr. Emily M. Leproust, Ph.D.

Twist Bioscience Corp(TWST)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Twist Bioscience Corp의 주식을 보유한 기관은 총 592곳이며, 이들이 보유한 주식의 총 가치는 약 78.48M로 전체 발행 주식의 126.03%를 차지합니다. 이는 2025Q4 대비 -339291.00 증가한 수치입니다.

Twist Bioscience Corp의 최대 수익원은 무엇인가요?

2026Q1 기준, Twist Bioscience Corp의 NGS applications 부문이 가장 높은 매출을 기록했으며, 금액은 52.64M로 전체 매출의 50.76%를 차지했습니다.